Deval Lashkari

Deval Lashkari is a highly experienced professional in the biotechnology and investment sectors, currently serving as a Senior Partner at Telegraph Hill Partners since 2001. In addition to this role, Deval Lashkari holds multiple directorships on the boards of various companies, including EditCo Bio, n6 Tec, Panome Bio, Mosaic Biosciences, Excellos, Cell Microsystems, Nimble Therapeutics, Dynex Technologies, and Carterra. Deval Lashkari earned a PhD in Genetics from Stanford University School of Medicine and a Bachelor of Arts in Genetics with Highest Honors from the University of California, Berkeley.